Brookstone Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$35.2M Buy
97,295
+20,957
+27% +$7.17M 0.35% 70
2026
Q1
$26.9M Buy
76,338
+1,929
+3% +$688K 0.31% 88
2025
Q4
$24.4M Buy
74,409
+3,098
+4% +$983K 0.28% 91
2025
Q3
$20.1M Buy
71,311
+16,042
+29% +$4.65M 0.24% 103
2025
Q2
$15.4M Buy
55,269
+5,517
+11% +$1.56M 0.2% 117
2025
Q1
$15.5M Buy
49,752
+30,500
+158% +$9.01M 0.22% 111
2024
Q4
$5.02M Buy
19,252
+1,462
+8% +$434K 0.07% 250
2024
Q3
$5.73M Buy
17,790
+1,214
+7% +$397K 0.08% 229
2024
Q2
$5.56M Buy
16,576
+8,350
+102% +$2.45M 0.09% 212
2024
Q1
$2.34M Sell
8,226
-45,873
-85% -$13.4M 0.04% 332
2023
Q4
$15.6M Sell
54,099
-6,101
-10% -$1.66M 0.3% 83
2023
Q3
$16.9M Sell
60,200
-8,331
-12% -$2.08M 0.37% 71
2023
Q2
$15M Buy
68,531
+3,725
+6% +$864K 0.3% 92
2023
Q1
$16.1M Buy
64,806
+57,482
+785% +$14.1M 0.31% 88
2022
Q4
$2.02M Sell
7,324
-40,089
-85% -$10.7M 0.04% 312
2022
Q3
$11.7M Buy
47,413
+3,375
+8% +$818K 0.27% 93
2022
Q2
$10.9M Buy
44,038
+12,570
+40% +$3.08M 0.24% 101
2022
Q1
$7.89M Buy
31,468
+4,531
+17% +$1.04M 0.15% 136
2021
Q4
$6.12M Buy
26,937
+20,659
+329% +$4.36M 0.11% 159
2021
Q3
$1.28M Sell
6,278
-1,563
-20% -$360K 0.02% 340
2021
Q2
$1.92M Buy
7,841
+3,112
+66% +$766K 0.03% 267
2021
Q1
$1.18M Sell
4,729
-483
-9% -$115K 0.05% 235
2020
Q4
$1.2M Sell
5,212
-499
-9% -$115K 0.05% 215
2020
Q3
$1.45M Buy
5,711
+1,356
+31% +$336K 0.07% 179
2020
Q2
$1.03M Sell
4,355
-2,465
-36% -$562K 0.06% 168
2020
Q1
$1.38M Sell
6,820
-2,391
-26% -$522K 0.08% 142
2019
Q4
$2.22M Sell
9,211
-1,628
-15% -$359K 0.11% 114
2019
Q3
$2.1M Sell
10,839
-2,873
-21% -$551K 0.11% 117
2019
Q2
$2.53M Buy
13,712
+11,262
+460% +$2.02M 0.15% 118
2019
Q1
$466K Sell
2,450
-998
-29% -$191K 0.03% 256
2018
Q4
$671K Sell
3,448
-4,499
-57% -$878K 0.05% 156
2018
Q3
$1.65M Sell
7,947
-108
-1% -$21.3K 0.13% 141
2018
Q2
$1.49M Buy
8,055
+3,823
+90% +$676K 0.13% 133
2018
Q1
$721K Buy
4,232
+373
+10% +$68.5K 0.07% 154
2017
Q4
$671K Sell
3,859
-336
-8% -$59.5K 0.06% 168
2017
Q3
$782K Sell
4,195
-364
-8% -$64.5K 0.07% 161
2017
Q2
$785K Buy
4,559
+61
+1% +$9.92K 0.07% 154
2017
Q1
$738K Buy
+4,498
New +$747K 0.07% 148
2015
Q4
Sell
-203
Closed -$28K 191
2015
Q3
$28K Sell
203
-286
-58% -$45.1K 0.01% 613
2015
Q2
$75K Buy
+489
New +$78.3K 0.01% 388

Other funds holding AMGN

Brookstone Capital Management's AMGN Position: Q2 2026 in Review

Brookstone Capital Management increased its Amgen (AMGN) stake by 27% in Q2 2026, buying an estimated $7.17M and bringing the position to 97,295 shares worth $35.2M. The position accounts for 0.35% of the portfolio, ranked #70.

Brookstone Capital Management first reported a position in AMGN in Q2 2015 and has held it in 40 quarters since. 1,228 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Brookstone Capital Management held 97,295 shares of Amgen worth $35.2M as of Q2 2026.
  • Brookstone Capital Management bought 20,957 Amgen shares in Q2 2026, an estimated $7.17M.
  • Amgen made up 0.35% of Brookstone Capital Management's portfolio in Q2 2026, its #70 holding.
  • Brookstone Capital Management first reported a position in Amgen in Q2 2015 and has held it in 40 quarters since.
  • 1,228 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Brookstone Capital Management's 13F filing for Q2 2026, filed 15 Jul 2026.